ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMRI Albany Molecular Research, Inc.

21.74
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Albany Molecular Research, Inc. NASDAQ:AMRI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 21.74 21.74 21.76 0 01:00:00

AMRI to Announce Second Quarter 2016 Results

15/07/2016 1:00pm

PR Newswire (US)


Albany Molecular Research, Inc. (NASDAQ:AMRI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Albany Molecular Research, Inc. Charts.

ALBANY, N.Y., July 15, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter 2016 financial results before the opening of the market on Thursday, August 4, 2016.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET.

The conference call can be accessed by dialing (866) 208-5728 (domestic calls) or (224) 633-1279 (international calls) at 8:20 a.m. ET and entering passcode 89843328. A live webcast with slides will also be available and can be accessed on the company's website at www.amriglobal.com. A replay of the conference call can be accessed for 24 hours at (855) 859-2056 (domestic calls) or (404) 537-3406 (international calls) and entering passcode 49003667. Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at http://ir.amriglobal.com.

About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing (DP). Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API supports the chemical development and cGMP manufacture of complex API, including potent and cytotoxic compounds, controlled substances, steroids, hormones, and sterile API. DPM supports development through commercial scale production of complex liquid-filled and lyophilized parenterals, sterile suspensions and ophthalmic formulations. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amri-to-announce-second-quarter-2016-results-300299098.html

SOURCE AMRI

Copyright 2016 PR Newswire

1 Year Albany Molecular Research, Inc. Chart

1 Year Albany Molecular Research, Inc. Chart

1 Month Albany Molecular Research, Inc. Chart

1 Month Albany Molecular Research, Inc. Chart

Your Recent History

Delayed Upgrade Clock